![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 47/50 | |
A61K 9/127 | |||
A61K 38/07 | |||
A61K 45/06 | |||
A61P 35/00 |
(11) | Number of the document | 2874606 |
(13) | Kind of document | T |
(96) | European patent application number | 13820351.8 |
Date of filing the European patent application | 2013-07-17 | |
(97) | Date of publication of the European application | 2015-05-27 |
(45) | Date of publication and mention of the grant of the patent | 2019-03-06 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/050872 |
Date | 2013-07-17 |
(87) | Number | WO 2014/015027 |
Date | 2014-01-23 |
(30) | Number | Date | Country code |
201261673017 P | 2012-07-18 | US | |
201361794603 P | 2013-03-15 | US |
(72) |
CHU, Katherine, A., US
CHAN, Elena, T., US
FANG, Ying, US
JUMAA, Mouhannad, US
KIRK, Christopher, Justin, US
MUCHAMUEL, Tony, Marcel, US
WANG, Zhengping, US
JIANG, Jing, US
JONES, Jeffrey, Joseph, US
|
(73) |
Onyx Therapeutics, Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
(54) | LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS |
LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS |